申请人:Chiesi S.A.
公开号:US06429229B1
公开(公告)日:2002-08-06
The invention concerns the use of compounds of general formula (I): (X)n1,Y,(Z)n2 wherein n1 and n2 represent 0 or 1; X represents a natural amino acid, in particular an amino acid selected among ornithine, arginine, lysine, histidine or glutamine; Y represents a keto acid of formula (II): R—CO—COOH wherein R represents —CH3, —CH2—CH3, —CH(CH3)2, —CH(CH3)—CH2—CH3, —CH2—CH(CH3)2, —CH2)2—COOH, —CH2)3—COOH; Z represents: a natural amino acid selected in particular among ornithine, arginine, lysine, histidine or glutamine; or a polyamine selected in particular among cadaverine, putrescine, spermidine, spermine or agmatine. Said compounds are useful for preparing a medicine for treating human or animal pathologies wherein are involved silent neurons, such as pathologies of the digestive tract, the bladder and the biliary ducts.
本发明涉及使用通式(I)的化合物:(X)n1,Y,(Z)n2,其中n1和n2表示0或1;X表示天然氨基酸,特别是在鸟氨酸,精氨酸,赖氨酸,组氨酸或谷氨酰胺中选择的氨基酸;Y表示式(II)的酮酸:R—CO—COOH,其中R表示—CH3,—CH2—CH3,—CH(CH3)2,—CH(CH3)—CH2—CH3,—CH2—CH(CH3)2,—CH2)2—COOH,—CH2)3—COOH;Z表示:特别是在鸟氨酸,精氨酸,赖氨酸,组氨酸或谷氨酰胺中选择的天然氨基酸;或者是特别在腐胺,腐胺,精胺,精氨酸或精胺中选择的多胺。这些化合物可用于制备用于治疗涉及沉默神经元的人类或动物病理的药物,例如消化道,膀胱和胆管病理。